nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—SHBG—Spironolactone—dilated cardiomyopathy	0.68	0.861	CbGbCtD
Estropipate—ALB—Furosemide—dilated cardiomyopathy	0.11	0.139	CbGbCtD
Estropipate—Breast cancer—Spironolactone—dilated cardiomyopathy	0.00946	0.0535	CcSEcCtD
Estropipate—Glucose tolerance decreased—Furosemide—dilated cardiomyopathy	0.00936	0.0529	CcSEcCtD
Estropipate—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.00697	0.0394	CcSEcCtD
Estropipate—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00532	0.0301	CcSEcCtD
Estropipate—Breast pain—Spironolactone—dilated cardiomyopathy	0.00396	0.0224	CcSEcCtD
Estropipate—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.00395	0.0223	CcSEcCtD
Estropipate—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00393	0.0222	CcSEcCtD
Estropipate—SLC22A1—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00328	0.1	CbGpPWpGaD
Estropipate—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00317	0.0179	CcSEcCtD
Estropipate—Leg pain—Lisinopril—dilated cardiomyopathy	0.00305	0.0172	CcSEcCtD
Estropipate—Thrombosis—Furosemide—dilated cardiomyopathy	0.00265	0.015	CcSEcCtD
Estropipate—Blister—Furosemide—dilated cardiomyopathy	0.00261	0.0147	CcSEcCtD
Estropipate—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.00232	0.0131	CcSEcCtD
Estropipate—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00226	0.0128	CcSEcCtD
Estropipate—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00222	0.0679	CbGpPWpGaD
Estropipate—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00214	0.0121	CcSEcCtD
Estropipate—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00205	0.0116	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.0018	0.055	CbGpPWpGaD
Estropipate—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00173	0.00975	CcSEcCtD
Estropipate—Bladder pain—Furosemide—dilated cardiomyopathy	0.0017	0.0096	CcSEcCtD
Estropipate—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00164	0.00926	CcSEcCtD
Estropipate—ESR2—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00164	0.05	CbGpPWpGaD
Estropipate—Breast pain—Lisinopril—dilated cardiomyopathy	0.00162	0.00913	CcSEcCtD
Estropipate—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.0016	0.00906	CcSEcCtD
Estropipate—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00159	0.009	CcSEcCtD
Estropipate—SHBG—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.00158	0.0481	CbGpPWpGaD
Estropipate—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00158	0.0089	CcSEcCtD
Estropipate—Cough increased—Lisinopril—dilated cardiomyopathy	0.00154	0.0087	CcSEcCtD
Estropipate—Alopecia—Spironolactone—dilated cardiomyopathy	0.00153	0.00866	CcSEcCtD
Estropipate—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00145	0.0082	CcSEcCtD
Estropipate—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00143	0.00806	CcSEcCtD
Estropipate—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00143	0.00806	CcSEcCtD
Estropipate—Purpura—Furosemide—dilated cardiomyopathy	0.00141	0.00799	CcSEcCtD
Estropipate—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00141	0.00796	CcSEcCtD
Estropipate—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00141	0.00796	CcSEcCtD
Estropipate—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00138	0.00778	CcSEcCtD
Estropipate—Cystitis—Lisinopril—dilated cardiomyopathy	0.00136	0.00769	CcSEcCtD
Estropipate—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00134	0.00756	CcSEcCtD
Estropipate—Irritability—Furosemide—dilated cardiomyopathy	0.0013	0.00735	CcSEcCtD
Estropipate—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00127	0.0072	CcSEcCtD
Estropipate—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00124	0.00698	CcSEcCtD
Estropipate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00123	0.00696	CcSEcCtD
Estropipate—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00123	0.00694	CcSEcCtD
Estropipate—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00119	0.0067	CcSEcCtD
Estropipate—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00117	0.00661	CcSEcCtD
Estropipate—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00116	0.00653	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—LAMA4—dilated cardiomyopathy	0.00113	0.0346	CbGpPWpGaD
Estropipate—Injury—Lisinopril—dilated cardiomyopathy	0.00111	0.00629	CcSEcCtD
Estropipate—Somnolence—Spironolactone—dilated cardiomyopathy	0.0011	0.00619	CcSEcCtD
Estropipate—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00106	0.00601	CcSEcCtD
Estropipate—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00106	0.00601	CcSEcCtD
Estropipate—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00106	0.00597	CcSEcCtD
Estropipate—SHBG—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.00104	0.0319	CbGpPWpGaD
Estropipate—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00104	0.0059	CcSEcCtD
Estropipate—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00102	0.00578	CcSEcCtD
Estropipate—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000994	0.00562	CcSEcCtD
Estropipate—Urticaria—Spironolactone—dilated cardiomyopathy	0.000979	0.00553	CcSEcCtD
Estropipate—Irritability—Lisinopril—dilated cardiomyopathy	0.000976	0.00552	CcSEcCtD
Estropipate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000974	0.0055	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000965	0.0295	CbGpPWpGaD
Estropipate—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000924	0.00522	CcSEcCtD
Estropipate—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000921	0.00521	CcSEcCtD
Estropipate—Visual impairment—Furosemide—dilated cardiomyopathy	0.000909	0.00514	CcSEcCtD
Estropipate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000908	0.00513	CcSEcCtD
Estropipate—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000892	0.00504	CcSEcCtD
Estropipate—Asthma—Lisinopril—dilated cardiomyopathy	0.000884	0.005	CcSEcCtD
Estropipate—Influenza—Lisinopril—dilated cardiomyopathy	0.000884	0.005	CcSEcCtD
Estropipate—Eye disorder—Furosemide—dilated cardiomyopathy	0.000881	0.00498	CcSEcCtD
Estropipate—Pruritus—Spironolactone—dilated cardiomyopathy	0.000871	0.00492	CcSEcCtD
Estropipate—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000867	0.0049	CcSEcCtD
Estropipate—Angiopathy—Furosemide—dilated cardiomyopathy	0.000856	0.00484	CcSEcCtD
Estropipate—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000852	0.00481	CcSEcCtD
Estropipate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000843	0.00476	CcSEcCtD
Estropipate—Dysuria—Lisinopril—dilated cardiomyopathy	0.000827	0.00467	CcSEcCtD
Estropipate—ESR1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000825	0.0252	CbGpPWpGaD
Estropipate—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000822	0.00464	CcSEcCtD
Estropipate—Erythema—Furosemide—dilated cardiomyopathy	0.000821	0.00464	CcSEcCtD
Estropipate—Malnutrition—Furosemide—dilated cardiomyopathy	0.000821	0.00464	CcSEcCtD
Estropipate—Dizziness—Spironolactone—dilated cardiomyopathy	0.000815	0.0046	CcSEcCtD
Estropipate—Flatulence—Furosemide—dilated cardiomyopathy	0.000809	0.00457	CcSEcCtD
Estropipate—Weight increased—Lisinopril—dilated cardiomyopathy	0.000805	0.00455	CcSEcCtD
Estropipate—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000798	0.00451	CcSEcCtD
Estropipate—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000789	0.00446	CcSEcCtD
Estropipate—Depression—Lisinopril—dilated cardiomyopathy	0.000786	0.00444	CcSEcCtD
Estropipate—Vomiting—Spironolactone—dilated cardiomyopathy	0.000783	0.00443	CcSEcCtD
Estropipate—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000777	0.00439	CcSEcCtD
Estropipate—Rash—Spironolactone—dilated cardiomyopathy	0.000777	0.00439	CcSEcCtD
Estropipate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000776	0.00438	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000773	0.0236	CbGpPWpGaD
Estropipate—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000773	0.00437	CcSEcCtD
Estropipate—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000773	0.00437	CcSEcCtD
Estropipate—Headache—Spironolactone—dilated cardiomyopathy	0.000772	0.00436	CcSEcCtD
Estropipate—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000746	0.00421	CcSEcCtD
Estropipate—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00074	0.00418	CcSEcCtD
Estropipate—Vertigo—Furosemide—dilated cardiomyopathy	0.000738	0.00417	CcSEcCtD
Estropipate—Nausea—Spironolactone—dilated cardiomyopathy	0.000732	0.00413	CcSEcCtD
Estropipate—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00071	0.00401	CcSEcCtD
Estropipate—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000702	0.00397	CcSEcCtD
Estropipate—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000697	0.00394	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000694	0.00392	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000688	0.021	CbGpPWpGaD
Estropipate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00067	0.00379	CcSEcCtD
Estropipate—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000669	0.00378	CcSEcCtD
Estropipate—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000657	0.00371	CcSEcCtD
Estropipate—Skin disorder—Furosemide—dilated cardiomyopathy	0.000651	0.00368	CcSEcCtD
Estropipate—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000642	0.00363	CcSEcCtD
Estropipate—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000638	0.0036	CcSEcCtD
Estropipate—Alopecia—Lisinopril—dilated cardiomyopathy	0.000625	0.00353	CcSEcCtD
Estropipate—ESR1—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000622	0.019	CbGpPWpGaD
Estropipate—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00062	0.0035	CcSEcCtD
Estropipate—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000616	0.00348	CcSEcCtD
Estropipate—Erythema—Lisinopril—dilated cardiomyopathy	0.000616	0.00348	CcSEcCtD
Estropipate—Flatulence—Lisinopril—dilated cardiomyopathy	0.000607	0.00343	CcSEcCtD
Estropipate—Tension—Lisinopril—dilated cardiomyopathy	0.000605	0.00342	CcSEcCtD
Estropipate—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000602	0.0034	CcSEcCtD
Estropipate—Nervousness—Lisinopril—dilated cardiomyopathy	0.000598	0.00338	CcSEcCtD
Estropipate—Back pain—Lisinopril—dilated cardiomyopathy	0.000596	0.00337	CcSEcCtD
Estropipate—Somnolence—Furosemide—dilated cardiomyopathy	0.000596	0.00337	CcSEcCtD
Estropipate—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000592	0.00335	CcSEcCtD
Estropipate—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000579	0.00327	CcSEcCtD
Estropipate—Fatigue—Furosemide—dilated cardiomyopathy	0.000578	0.00326	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.000575	0.0176	CbGpPWpGaD
Estropipate—Constipation—Furosemide—dilated cardiomyopathy	0.000573	0.00324	CcSEcCtD
Estropipate—Pain—Furosemide—dilated cardiomyopathy	0.000573	0.00324	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000569	0.0174	CbGpPWpGaD
Estropipate—Angioedema—Lisinopril—dilated cardiomyopathy	0.000563	0.00318	CcSEcCtD
Estropipate—Vertigo—Lisinopril—dilated cardiomyopathy	0.000554	0.00313	CcSEcCtD
Estropipate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000548	0.0031	CcSEcCtD
Estropipate—Palpitations—Lisinopril—dilated cardiomyopathy	0.000544	0.00308	CcSEcCtD
Estropipate—Cough—Lisinopril—dilated cardiomyopathy	0.000538	0.00304	CcSEcCtD
Estropipate—Urticaria—Furosemide—dilated cardiomyopathy	0.000532	0.00301	CcSEcCtD
Estropipate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00053	0.00299	CcSEcCtD
Estropipate—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00053	0.00299	CcSEcCtD
Estropipate—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000525	0.00296	CcSEcCtD
Estropipate—Myalgia—Lisinopril—dilated cardiomyopathy	0.000525	0.00296	CcSEcCtD
Estropipate—Anxiety—Lisinopril—dilated cardiomyopathy	0.000523	0.00295	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000521	0.00294	CcSEcCtD
Estropipate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000503	0.00284	CcSEcCtD
Estropipate—Oedema—Lisinopril—dilated cardiomyopathy	0.000503	0.00284	CcSEcCtD
Estropipate—Infection—Lisinopril—dilated cardiomyopathy	0.0005	0.00282	CcSEcCtD
Estropipate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000494	0.00279	CcSEcCtD
Estropipate—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000488	0.00276	CcSEcCtD
Estropipate—Asthenia—Furosemide—dilated cardiomyopathy	0.000481	0.00272	CcSEcCtD
Estropipate—Pruritus—Furosemide—dilated cardiomyopathy	0.000474	0.00268	CcSEcCtD
Estropipate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000459	0.00259	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000458	0.00259	CcSEcCtD
Estropipate—Insomnia—Lisinopril—dilated cardiomyopathy	0.000455	0.00257	CcSEcCtD
Estropipate—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000452	0.00255	CcSEcCtD
Estropipate—Somnolence—Lisinopril—dilated cardiomyopathy	0.000447	0.00253	CcSEcCtD
Estropipate—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000445	0.0136	CbGpPWpGaD
Estropipate—Dizziness—Furosemide—dilated cardiomyopathy	0.000443	0.0025	CcSEcCtD
Estropipate—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000443	0.0025	CcSEcCtD
Estropipate—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000434	0.00245	CcSEcCtD
Estropipate—Fatigue—Lisinopril—dilated cardiomyopathy	0.000434	0.00245	CcSEcCtD
Estropipate—Pain—Lisinopril—dilated cardiomyopathy	0.00043	0.00243	CcSEcCtD
Estropipate—Constipation—Lisinopril—dilated cardiomyopathy	0.00043	0.00243	CcSEcCtD
Estropipate—Vomiting—Furosemide—dilated cardiomyopathy	0.000426	0.00241	CcSEcCtD
Estropipate—Rash—Furosemide—dilated cardiomyopathy	0.000423	0.00239	CcSEcCtD
Estropipate—Dermatitis—Furosemide—dilated cardiomyopathy	0.000422	0.00239	CcSEcCtD
Estropipate—Headache—Furosemide—dilated cardiomyopathy	0.00042	0.00237	CcSEcCtD
Estropipate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000411	0.00232	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.000402	0.0123	CbGpPWpGaD
Estropipate—Urticaria—Lisinopril—dilated cardiomyopathy	0.000399	0.00226	CcSEcCtD
Estropipate—Nausea—Furosemide—dilated cardiomyopathy	0.000398	0.00225	CcSEcCtD
Estropipate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000397	0.00225	CcSEcCtD
Estropipate—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000397	0.00225	CcSEcCtD
Estropipate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00037	0.00209	CcSEcCtD
Estropipate—Asthenia—Lisinopril—dilated cardiomyopathy	0.000361	0.00204	CcSEcCtD
Estropipate—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000357	0.0109	CbGpPWpGaD
Estropipate—Pruritus—Lisinopril—dilated cardiomyopathy	0.000356	0.00201	CcSEcCtD
Estropipate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000344	0.00194	CcSEcCtD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00034	0.0104	CbGpPWpGaD
Estropipate—Dizziness—Lisinopril—dilated cardiomyopathy	0.000333	0.00188	CcSEcCtD
Estropipate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00032	0.00181	CcSEcCtD
Estropipate—Rash—Lisinopril—dilated cardiomyopathy	0.000317	0.00179	CcSEcCtD
Estropipate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000317	0.00179	CcSEcCtD
Estropipate—Headache—Lisinopril—dilated cardiomyopathy	0.000315	0.00178	CcSEcCtD
Estropipate—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00031	0.00946	CbGpPWpGaD
Estropipate—Nausea—Lisinopril—dilated cardiomyopathy	0.000299	0.00169	CcSEcCtD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000295	0.00901	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000291	0.00888	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000287	0.00876	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000283	0.00863	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000268	0.0082	CbGpPWpGaD
Estropipate—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000266	0.00813	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000263	0.00805	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.000257	0.00785	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000251	0.00766	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000233	0.00711	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.000223	0.00681	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000222	0.0068	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	0.000222	0.00678	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000209	0.0064	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000205	0.00627	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000202	0.00618	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.000198	0.00606	CbGpPWpGaD
Estropipate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000193	0.00588	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.000187	0.00572	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	0.000185	0.00566	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000184	0.00562	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000182	0.00555	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000178	0.00543	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000177	0.00542	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000177	0.00542	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000174	0.00532	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000174	0.00532	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00017	0.00521	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000158	0.00484	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000143	0.00435	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000142	0.00433	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000138	0.00422	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000137	0.0042	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—NR3C2—dilated cardiomyopathy	0.000136	0.00416	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000135	0.00413	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000135	0.00413	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000125	0.00381	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.000123	0.00375	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000123	0.00375	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000119	0.00363	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000118	0.0036	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000117	0.00357	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000115	0.00352	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000113	0.00345	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000112	0.00344	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000107	0.00328	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000107	0.00328	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000106	0.00323	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000106	0.00323	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000104	0.00319	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000103	0.00314	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000103	0.00314	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.81e-05	0.003	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.56e-05	0.00292	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	9.28e-05	0.00284	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	9.11e-05	0.00278	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	8.95e-05	0.00273	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	8.95e-05	0.00273	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	8.86e-05	0.00271	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.77e-05	0.00268	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—NPPA—dilated cardiomyopathy	8.54e-05	0.00261	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.54e-05	0.00261	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TTN—dilated cardiomyopathy	8.17e-05	0.0025	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.03e-05	0.00245	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.91e-05	0.00242	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	7.67e-05	0.00234	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.53e-05	0.0023	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.3e-05	0.00223	CbGpPWpGaD
Estropipate—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	7.08e-05	0.00216	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.07e-05	0.00216	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	6.98e-05	0.00213	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	6.95e-05	0.00212	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.88e-05	0.0021	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.88e-05	0.0021	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.86e-05	0.0021	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	6.86e-05	0.0021	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	6.6e-05	0.00202	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	6.53e-05	0.002	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.39e-05	0.00195	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VCL—dilated cardiomyopathy	6.02e-05	0.00184	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	5.91e-05	0.0018	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.82e-05	0.00178	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	5.37e-05	0.00164	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	5.26e-05	0.00161	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	5.26e-05	0.00161	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	5.06e-05	0.00155	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	5.01e-05	0.00153	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.01e-05	0.00153	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	5e-05	0.00153	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	4.81e-05	0.00147	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	4.79e-05	0.00146	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	4.71e-05	0.00144	CbGpPWpGaD
Estropipate—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	4.65e-05	0.00142	CbGpPWpGaD
Estropipate—ALB—Metabolism—TAZ—dilated cardiomyopathy	4.37e-05	0.00133	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	4.31e-05	0.00132	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.26e-05	0.0013	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.99e-05	0.00122	CbGpPWpGaD
Estropipate—ALB—Metabolism—SDHA—dilated cardiomyopathy	3.95e-05	0.00121	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	3.88e-05	0.00118	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	3.8e-05	0.00116	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.8e-05	0.00116	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	3.58e-05	0.00109	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.25e-05	0.000993	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	3.23e-05	0.000988	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.13e-05	0.000955	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	3.06e-05	0.000934	CbGpPWpGaD
Estropipate—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	3.02e-05	0.000924	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	2.76e-05	0.000844	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.71e-05	0.000829	CbGpPWpGaD
Estropipate—ALB—Hemostasis—CD36—dilated cardiomyopathy	2.58e-05	0.000788	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.51e-05	0.000766	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RAC1—dilated cardiomyopathy	2.43e-05	0.000742	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.41e-05	0.000736	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.41e-05	0.000736	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.41e-05	0.000736	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.36e-05	0.000721	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.35e-05	0.000717	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.24e-05	0.000684	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.17e-05	0.000663	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.13e-05	0.000652	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.11e-05	0.000646	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.09e-05	0.000637	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.97e-05	0.000603	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.92e-05	0.000587	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.85e-05	0.000566	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.76e-05	0.000537	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.73e-05	0.000529	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.69e-05	0.000515	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.64e-05	0.000502	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.61e-05	0.000492	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	1.6e-05	0.00049	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	1.56e-05	0.000477	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.51e-05	0.000461	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.48e-05	0.000452	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	1.41e-05	0.00043	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.39e-05	0.000426	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.36e-05	0.000417	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	1.3e-05	0.000398	CbGpPWpGaD
Estropipate—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.07e-05	0.000328	CbGpPWpGaD
Estropipate—ALB—Metabolism—CD36—dilated cardiomyopathy	1.05e-05	0.000319	CbGpPWpGaD
Estropipate—ALB—Metabolism—AGT—dilated cardiomyopathy	9.41e-06	0.000288	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.05e-06	0.000276	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	8.79e-06	0.000268	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	8.56e-06	0.000261	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	7.7e-06	0.000235	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	7.51e-06	0.000229	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	7.31e-06	0.000223	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	6.58e-06	0.000201	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.2e-06	0.00019	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.8e-06	0.000177	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.64e-06	0.000172	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.08e-06	0.000155	CbGpPWpGaD
